We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA May Extend NDA Pathway to Increase Access to Nonprescription Drugs
FDA May Extend NDA Pathway to Increase Access to Nonprescription Drugs
The FDA proposes to extend the new drug application pathway to include therapeutic indications that have not previously been available for nonprescription drugs, Commissioner Scott Gottlieb said on Tuesday in announcing a new draft guidance on the initiative.